Sugi Predict

Sugi Predict / Compounds / SCHEMBL4472703

SCHEMBL4472703

SCHEMBL4472703

COc1ccc(Nc2sc(C(=O)c3coc4ccccc34)c(N)c2C#N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ GAA P10253 2/20 0.53
▸ POLB P06746 4/20 0.52
▸ HPGD P15428 3/20 0.52
▸ HTT P42858 3/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ KMT2A Q03164 5/20 0.49
▸ LMNA P02545 4/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ MELK Q14680 3/20 0.49
▸ ALOX12 P18054 1/20 0.49
▸ MAOB P27338 1/20 0.47
▸ RAB9A P51151 4/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4476614 0.82 MAPT (0.58) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4479525 0.81 LMNA (0.49) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4473381 0.81 ALDH1A1 (0.80) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL2132475 0.80 ALDH1A1 (0.74) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4496937 0.79 MAPT (0.80) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4487871 0.79 MAPT (0.55) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL631695 0.79 ALDH1A1 (0.54) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4476805 0.78 MAPT (0.46) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4487530 0.78 MELK (0.47) MAPTALDH1A1GAAPOLBMELK
SCHEMBL4512080 0.78 ALDH1A1 (0.71) MAPTALDH1A1GAAPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A MAPT 3524/4885ALDH1A1 802/4885GAA 77/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A MAPT 3524/4885ALDH1A1 802/4885GAA 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.